Target intelligence / Profile preview

T-cell homing

Molecular classification
Other (multimolecular process), Integrin, Selectin, Chemokine receptor
01

Overview

T-cell homing refers to the highly regulated process governing the migration of T lymphocytes from the bloodstream to specific tissues, determined by expression of surface receptors such as selectins, integrins, and chemokine receptors. These molecules interact with ligands on vascular endothelium, guiding T-cell entry into lymphoid organs, inflamed tissues, or tumors. The process is essential for normal immune surveillance, adaptive responses, and, in pathology, influences the development and outcome of inflammation, autoimmunity, cancer, and infection. Drugs targeting components of the homing machinery have clinical relevance for treating autoimmune diseases, inflammatory bowel disease, and certain cancers.

Other names
T-cell traffickingLymphocyte homingT-cell migration
02

Mechanism of action

Blockade of homing receptors to prevent T-cell entry to tissue; Modulation of chemokine receptor signaling; Inhibition of integrin-mediated adhesion

03

Biological functions

Cell migrationImmune responseTissue localizationInflammationTumor infiltration
04

Disease associations

InflammationCancerAutoimmune diseaseInfectionOther
05

Safety considerations

Blocking T-cell homing can increase risk of infection (impaired immune surveillance)May provoke immune-related adverse events if T-cell localization is dysregulatedGut-specific integrin inhibitors can cause GI complicationsRebound inflammation on drug withdrawal
06

Interacting drugs

Natalizumab

3 more in the full profile.

07

Biomarkers

Expression of homing receptors (e.g., CD62L, CCR7, α4β7) on T-cell subsetsFlow/cytometry detection of surface markers

Beyond the preview

Go deeper on T-cell homing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell homing.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call